Incannex Healthcare Inc. Contract Liability (Deferred Revenue)
Incannex Healthcare Inc. (IXHL) had Contract Liability (Deferred Revenue) of $30.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-05-15
- 2026-03-31: Contract with Customer, Liability, Current $30.00K.
- 2025-12-31: Contract with Customer, Liability, Current $30.00K.
- 2025-09-30: Contract with Customer, Liability, Current $30.00K.
- 2025-06-30: Contract with Customer, Liability, Current $30.00K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2026-03-31 | $30.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $30.00K 10-Q · filed 2026-02-13 |
| 2025-09-30 | $30.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $30.00K 10-Q · filed 2026-05-15 |
| 2025-03-31 | $28.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $27.00K 10-Q · filed 2025-02-14 |
| 2024-09-30 | $59.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $85.00K 10-K · filed 2025-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B |